Heart Test Laboratories, Inc. (NASDAQ: HSCS) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $15.00 price target on the stock.
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results [Yahoo! Finance]
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results